genetically engineered cells injected human patient first time monday federally approved experiment designed enhance already novel cancer therapy this first round gene transfer experiments gene inserted patients white blood cells expected directly benefit individual patient instead inserted gene used track movement body cancerfighting white blood cells nonetheless technique gene insertion could produce therapeutic results wide range diseases national institutes health director james b wyngaarden said statement mondays experiment designed track special laboratorygrown white blood cells known tumorinfiltrating lymphocytes tils the tils turn attack cancer using gene transfer technology developed w french anderson national heart lung blood institute national cancer institutes r michael blaese nih team inserted til cells bacterial gene inactivates drug neomycin this allow track cells patients the bacterial gene acts marker affected cells giving ability resist version neomycin called g418 poisons human cells the researchers routinely take blood samples biopsies patients either treat white blood cells g418 kill genetically changed til cells probe dna white blood cells find genetic marker inserting human genes repair defects may one day help host inherited disorders including cystic fibrosis duchennes muscular dystrophy gene insertion might also help brain disorders alzheimers disease illnesses growth disorders heart disease caused alterations way cholesterol metabolized defects immune system